Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Chinese Journal of Pathophysiology ; (12): 260-266, 2019.
Artigo em Chinês | WPRIM | ID: wpr-744237

RESUMO

AIM:To investigate the effect of CUDC-907, a dual histone deacetylase (HDAC) and phosphatidylinositol 3-kinase (PI3K) inhibitor, on the DNA damage, cell cycle distribution and autophagy in human glioma U251cells.METHODS:U251 cells were treated with CUDC-907 of different concentrations, and the cell viability was detected by MTT assay.The quantitativeγ-H2AX foci were determined by laser scanning confocal microscopy.The cell cycle distribution of U251 cells was examined by flow cytometry.The protein expression was determined by Western blot analysis.RESULTS:CUDC-907 inhibited the cell viability and the phosphorylation of Akt and p70 ribosomal protein S6 kinase (p70s6K) in the U251 cells (P<0.05).In CUDC-907-treated cells, the number ofγ-H2AX foci and protein expression ofγ-H2AX were increased significantly (P<0.05).CUDC-907 also induced cell arrest in theM phase by up-regulating the expression of p21, and inhibiting the protein level of cyclin B1 and the phosphorylation of cell division cycle protein2 (Cdc2).In addition, CUDC-907 triggered cell autophagy, and inhibition of autophagy increased CUDC-907-induced DNA damage of U251 cells.CONCLUSION:CUDC-907 significantly inhibits PI3K/Akt signaling pathway, induces DNA damage and arrests cell cycle inM phase.Blockage of autophagy promotes CUDC-907-induced DNA damage of U251cells.

2.
Chinese Journal of Pathophysiology ; (12): 200-205, 2018.
Artigo em Chinês | WPRIM | ID: wpr-701102

RESUMO

AIM:To investigate the effect of SCH900776, an inhibitor of checkpoint kinase 1(CHK1), on the proliferation and migration abilities of human glioma U 251 cells.METHODS:The cell viability was detected by MTT assay,and cell proliferation was determined by cell colony formation assay.Cell cycle distribution was analyzed by flow cy-tometry.Wound healing assay was used to determine the cell migration ability.The protein levels were determined by Western blot.RESULTS: SCH900776 inhibited the growth of U251 cells in a dose-dependent manner(P <0.05). SCH900776 treatment substantially induced U251 cell cycle arrest in S and G 2/M phases by decreasing the level of cell di-vision cycle protein 2(Cdc2)and p-Cdc2.Moreover,SCH900776 inhibited the cell migration.Western blot results indi-cated that SCH900776 increased the phosphorylation level of p 38 MAPK and inhibited the activation of Akt.CONCLU-SION:SCH900776 inhibits the proliferation and migration abilities in human U 251 cells by promoting the phosphorylation of p38 MAPK and suppressing the activation of Akt.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA